Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Mono- and disulfo-substituted anthraquinones and their use for the treatment of bone matrix disorders

Mono- and disulfo-substituted anthraquinones and their use for the treatment of bone matrix disorders

US Patent 5856358 · Granted Jan 5, 1999

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pharmaceutical formulation for the treatment of osteoarthritis containing clodro2018
Cyclic hydroxylamine as psychoactive compounds2011
Cyclic hydroxylamine as psychoactive compounds2010
Cyclic hydroxylamine as psychoactive compounds2010
Catalytic monoclonal antibodies with protease activity for selective lysis of pr2002
Acylamino-alkyliden-hydroxy-bisphosphonic acids esters and salts thereof, wherei1995
Anthraquinone compounds useful to treat osteoarticular conditions, pharmaceutica1995
4,5-dihydroxy- and 4,5,8-trihydroxy- 9,10-dihydro-9,10-dioxo-2-anthracenecarboxy1994
Arylalkyl esters of 4,5-dihydroxy-9,10-dihydro-9,10-dioxo-2-anthracenecarboxylic1994
Pharmaceutical compositions based on diphosphonates for the treatment of arthros1989
Pharmacologically active biphosphonates, process for the preparation thereof and1986
Pharmaceutical compositions for the treatment of osteopathias1986